Wockhardt UK Limited

Information

Name

Type

Company

Roles

Supplier

Company Size

Sme

Company Number

Incorporation Date

Website

http://www.wockhardt.co.uk

Address

Wrexham

United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Wockhardt UK Limited
Sign up free

Contracts awarded to Wockhardt UK Limited

The contracts that Wockhardt UK Limited have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 3 weeks ago

NP39724b Pomalidomide and Thalidomide

Supply of pomalidomide capsules and thalidomide capsules to NHS Scotland.

£959,680
Award

Published 2 months ago

NHS National Generic Pharmaceuticals Wave 15a

NHS National Generic Pharmaceuticals - Wave 15a. Offer reference number: CM/PHG/23/5697. Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/23/5697/01 – Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN): 01/02/2025 to 31/05/2027 (28 Months) CM/PHG/23/5697/02 – Hospital Only Products: DNW & DLN: 01/02/2025 to 31/01/2027 (24 months) CM/PHG/23/5697/03 – Hospital Only Products (Housekeeping): DLS & DNE: 01/02/2025 to 31/05/2026 (16 months) DCE & DSW: 01/02/2025 to 30/09/2025 (8 months)

£170
Award

Published 6 months ago

NP35924b Rivaroxaban Tablets

Supply of rivaroxaban tablets to NHS Scotland

£81,156
Award

Published 8 months ago

Heparins & Anticoagulants

Heparins & Anticoagulants

£26,298,395
Award

Published 9 months ago

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)

Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)

£424,035,364 Bids close: 1 year ago
Award

Published 9 months ago

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 Offer reference number: CM/PHR/22/5682 CM/PHR/22/5682/01 - NHS Framework Agreement for Branded Medicines - National Tender - Lot 1. Period of framework: 1 May 2024 to 30 April 2028. CM/PHR/22/5682/02 - NHS Framework Agreement for Branded Medicines - National Tender - Lot 2. Period of framework: 1 May 2024 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Bids close: 1 year ago

Contacts

+44 1978661261

[email protected]

+44 1978661261

Statistics (1 Year)

Contracts Won

Total Won

£77,437,322

Average Win

£15,487,464

Wockhardt UK Limited

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Wockhardt UK Limited

NP39724b Pomalidomide and Thalidomide

NHS National Generic Pharmaceuticals Wave 15a

NP35924b Rivaroxaban Tablets

Heparins & Anticoagulants

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win